Patents
Patents for C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809)
07/2007
07/04/2007CN1990499A Further syntheses of cyproterone acetate
06/2007
06/28/2007US20070149490 process for the extraction of betulinic acid
06/26/2007US7235267 Brain cell or nerve cell-protecting agents comprising medicinal ginseng
06/21/2007US20070142345 Steroids for cancer treatment
06/20/2007EP0973791B1 Process for the preparation of an epoxy compound
06/13/2007EP1795200A1 Medicine and food/beverage for ameliorating hyperglycemia
06/13/2007EP1794177A2 Process for preparing 7 -alkoxycarbonyl substituted steroids
06/12/2007CA2393758C Unsaturated 14,15-cyclopropano-androstanes
06/06/2007CN1319984C Cyclovirobuxine extraction and purification method
06/05/2007USRE39678 Meiosis regulating compounds
05/2007
05/23/2007EP1196427B1 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof
05/15/2007CA2347345C Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds
05/10/2007US20070105826 Novel fusidic acid derivatives
05/09/2007CN1958597A Triterpene saponin compound of cycro jackfruit alkyl, and effect for anti tumor
05/09/2007CN1314402C Drug composition containing fructus tribuli fruit total saponin and its preparation method
04/2007
04/25/2007CN1951410A Protecting agent for brain cell or nerve cell, consisting of ginseng
04/19/2007WO2007043305A1 Agent for amelioration of insulin resistance
04/19/2007US20070088009 Triterpene quaternary salts as biologically active surfactants
04/18/2007EP1597267A4 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues
04/11/2007EP1772462A2 Steroid sulfamates, method for the production and use thereof
04/11/2007EP1771461A2 Novel 2-substituted estra-1,3,5(10)-trien-17-ones used in the form of inhibitors of 17beta-hydroxysteroiddehydrogenase of type 1
04/11/2007CN1946735A Pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
04/11/2007CN1944454A Anti-cancer compound, method for extracting said compound, composition containing said compound, and its use in medicine production
04/10/2007CA2135608C Contraception using competitive progesterone antagonists, and novel compounds useful therefor
04/03/2007US7199114 Triterpene quaternary salts as biologically active surfactants
03/2007
03/21/2007CN1934125A 黄体酮受体调节剂 Progesterone receptor modulators
03/21/2007CN1931176A Aescin medicine composition and its prepn process and use
03/21/2007CN1305893C Improved synthesis of cyproterone acetate
03/15/2007US20070060746 Processes for preparation of 9,11 epoxy steroids and intermediates useful therein
03/07/2007CN1923843A Preparation method of water-soluble C-27 steride glycoside
03/01/2007US20070049747 Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes
03/01/2007US20070048252 Conjugates of the hydrophilic polymer and the molecules from boxwood extraction, and pharmaceutical compositions of the conjugates
02/2007
02/21/2007CN1916016A Antiinflammation compound
02/21/2007CN1916015A Amine, heterocycle of chemical modification object of ursolic acid
02/21/2007CN1916014A Extractive of alfalfa, preparation method and usage
02/14/2007EP1752464A1 A precess for preparation of timosaponin b ii
02/14/2007CN1911954A Glycyrrhizic acid derivative having amino acid, its preparation method and medicinal composition containing them
02/08/2007WO2006031756A3 Betulinol derivatives as anti-cancer agents
02/01/2007US20070027128 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
01/2007
01/31/2007CN1903872A Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds
01/25/2007WO2007009821A1 Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes
01/25/2007CA2614804A1 Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes
01/24/2007EP1746101A1 Process for the production of Oxo-pregn-4-en-21,17-carbolactonen by metal free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes
01/24/2007CN1900105A Compound with anti-tumor activity and its preparing method
01/18/2007WO2006053255A3 Novel betulin derivatives, preparation thereof and use thereof
01/04/2007WO2007002411A1 Antiviral compounds
01/04/2007WO2005077968B1 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
01/04/2007CA2609280A1 Antiviral compounds
01/03/2007CN1887899A Amino alcohol as chemical modifier for ursolic acid
01/03/2007CN1887898A Amino acid as chemical modifier for ursolic acid
01/02/2007CA2347346C Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds
12/2006
12/27/2006EP1735330A1 Progesterone receptor modulators
12/26/2006US7153979 For therapy of hepatic disorders
12/20/2006EP1068219B1 Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
12/13/2006EP1730163A1 Pharmaceuticals salts of 3-o-(3,3-dimethylsuccinyl) betulinic acid
12/12/2006US7148213 Steroids with fluoroalkyl groups as antigestation steroids used in gynecological treatment
12/05/2006US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
12/05/2006CA2215067C Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this
11/2006
11/29/2006CN1871251A Novel triterpene derivatives, preparation thereof and use thereof
11/23/2006WO2006124956A1 Compounds useful for treating neurodegenerative disorders
11/23/2006WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006CA2609021A1 Compounds useful for treating neurodegenerative disorders
11/22/2006EP0970104B1 Steroid sulfamates, method for the production and use thereof
11/22/2006CN1867578A The conjugates of a hydrophilic polymer-buxus's extracts and the pharmaceutical compositions of thereof
11/16/2006WO2005077968A8 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
11/15/2006EP1487554A4 Methods for treating deodorizer distillate
11/08/2006CN1859917A Medicine and food/beverage for ameliorating hyperglycemia
11/07/2006US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/02/2006EP1716166A2 17-methylene- or 17-spiro-cyclopropane 7-substituted estra-1,3,5(10)-triene derivatives with anti-estrogenic activity
10/2006
10/31/2006US7129345 Keto-substituted steroid compounds
10/25/2006CN1850849A 25-hydroxy dioscin ketone, and its preparing method and use
10/25/2006CN1850848A 3-P-chlorophenyl formyloxy-15,16-methylene-5-androstene-17-one, and its synthesizing method
10/24/2006US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/11/2006EP1471896B1 Formulations for inhalation
10/11/2006CN1844132A Method for extraction preparation of astragaloside
10/10/2006CA2273343C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
09/2006
09/26/2006US7112670 Crystal form
09/26/2006US7112669 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
09/21/2006US20060211873 Synthesis of cyproterone acetate
09/14/2006US20060205697 Novel betulin derivatives, preparation thereof and use thereof
09/07/2006US20060199782 Gene therapy using a SYN3 and SYN3 homolog delivery enhancing agent with an interferon protein or an interferon gene delivery system; anticarcinogenic agents
08/2006
08/31/2006WO2006003013B1 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1
08/31/2006WO2005077968A3 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
08/31/2006US20060194774 Increased activity for the treatment of carcinomas and HIV diseases, melanoma, neuroectodermal tumor, sarcoma
08/30/2006CN1272340C Oleanolic acid couple derivatives and their pharmaceutical use
08/29/2006CA2212856C Benzopyran-containing compounds and method for their use
08/17/2006WO2006032970A3 PROCESS FOR PREPARING 7α-ALKOXYCARBONYL SUBSTITUTED STEROIDS
08/15/2006US7091195 Derived from plants; for preventing or inhibiting tumor growth
08/10/2006WO2006082126A1 Tetracyclic terpene series compounds, methods for preparing same, uses thereof as medicines and pharmaceutical compounds containing same
08/10/2006WO2004105694A3 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
08/10/2006CA2601724A1 Tetracyclic terpene series compounds, methods for preparing same, uses thereof as medicines and pharmaceutical compounds containing same
08/09/2006CN1814616A Buxine, buxine hydrochloride, and its preparing method and formulation
07/2006
07/20/2006US20060159622 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues
07/18/2006US7078396 Method of treating disorder related to high cholesterol concentration
07/13/2006WO2006072467A1 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
07/13/2006DE19713768B4 Herstellung von Betulinsäure Production of betulinic
07/13/2006DE102004063864A1 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate 18-methyl-19-nor-17-pregn-4-en21,17-carbolactones, and pharmaceutical compositions containing them
07/05/2006EP1675866A1 Novel triterpene derivatives, preparation thereof and use thereof
06/2006
06/22/2006WO2006003013A3 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1
06/22/2006US20060135495 multiple modes of activity; compounds useful for the treatment of strains of HIV that are resistant to treatment with other known compounds like DSB and RPR103611; cyclopenta[a]chrysene derivatives 3a-substituted with a carboxyalkylcarbamoyl group and 9-substituted with a carboxyalkylcarbonyloxy group
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 19